I'm thinking about trialing
enclomiphene soon; what I generally see from online user reports is that people have low testosterone levels overall (backed by bloods), then hop on (en)clomiphene, and they tend to report higher total testosterone after weeks of trial,
presumably from the ER antagonist effect from clomiphene at pituitary and hypothalamus;
however, I wonder why, if most of them had low total testosterone levels to begin with, therefore with already low e2 sensing at ERs in pituitary and hypothalamus, they would then report dramatically increases in pituitary LH secretion from the low e2 sensing induced by the ER blocking effects of clomiphene, while e2 sensing was already low off the drug, ans they still had low LH levels before ?